Literature DB >> 26611555

Corticosteroids in Sarcoidosis.

Marc A Judson1.   

Abstract

Corticosteroids are the drug of choice for the treatment of sarcoidosis. Because the natural course of sarcoidosis may be self-limiting and/or cause no long-term harm, treatment is not mandatory. Corticosteroids are usually effective for all forms of sarcoidosis, and they work quickly. However, because of the potential toxicities of corticosteroids, alternative medications often need to be considered. Efforts should be made to minimize the corticosteroid dose while keeping the risk of toxicity as low as possible. This article outlines the indications for corticosteroid therapy for sarcoidosis, discusses various dosing regimens, and suggests when alternative corticosteroid agents should be considered.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Corticosteroids; Sarcoidosis; Toxicity; Treatment

Mesh:

Substances:

Year:  2015        PMID: 26611555     DOI: 10.1016/j.rdc.2015.08.012

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  7 in total

1.  Case Study: Cardiac sarcoidosis resolved with Mycobacterium avium paratuberculosis antibiotics (MAP).

Authors:  Branko G Celler
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

2.  The Burden of Comorbidity and Complexity in Sarcoidosis: Impact of Associated Chronic Diseases.

Authors:  Pilar Brito-Zerón; Nihan Acar-Denizli; Antoni Sisó-Almirall; Xavier Bosch; Fernanda Hernández; Sergi Vilanova; Mireia Villalta; Belchin Kostov; Marina Paradela; Marcelo Sanchez; José Ramírez; Africa Muxí; Antonio Berruezo; Celeste Galceran-Chaves; Antoni Xaubet; Carles Agustí; Jacobo Sellarés; Manuel Ramos-Casals
Journal:  Lung       Date:  2017-12-11       Impact factor: 2.584

3.  Consecutive episodes of heart and kidney failure in an "otherwise" healthy young man.

Authors:  V Esposito; D Catucci; M Colucci; M Torreggiani; F Grosjean; C Esposito
Journal:  BMC Nephrol       Date:  2019-06-20       Impact factor: 2.388

4.  When the Game Changes: Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic.

Authors:  Nadera J Sweiss; Peter Korsten; Huzaefah J Syed; Aamer Syed; Robert P Baughman; Arthur M F Yee; Daniel A Culver; Teresa Sosenko; Arata Azuma; Francesco Bonella; Ulrich Costabel; Wonder P Drake; Marjolein Drent; Elyse E Lower; Dominique Israel-Biet; Remy L M Mostard; Hilario Nunes; Paola Rottoli; Paolo Spagnolo; Athol U Wells; Wim A Wuyts; Marc A Judson
Journal:  Chest       Date:  2020-04-29       Impact factor: 9.410

5.  Pulmonary sarcoidosis with and without extrapulmonary involvement: a cross-sectional and observational study in China.

Authors:  Cheng-Wei Li; Ru-Jia Tao; Dan-Feng Zou; Man-Hui Li; Xin Xu; Wei-Jun Cao
Journal:  BMJ Open       Date:  2018-02-16       Impact factor: 2.692

Review 6.  Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns.

Authors:  Marc A Judson
Journal:  F1000Res       Date:  2019-12-30

7.  Rare case of pulmonary sarcoidosis with cystic bronchiectasis.

Authors:  Keishi Sugino; Atsuko Kurosaki; Sakae Homma; Kazuma Kishi
Journal:  BMJ Case Rep       Date:  2020-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.